[HTML][HTML] Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi… - … England Journal of …, 2018 - Mass Medical Soc
Background Standard first-line therapy for metastatic, squamous non–small-cell lung cancer
(NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with programmed …
(NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with programmed …
[引用][C] Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer
L Paz-Ares, D Vicente, A Luft, A Tafreshi… - New England Journal …, 2018 - elibrary.ru
[引用][C] Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente… - New England …, 2018 - tobias-lib.ub.uni-tuebingen.de
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer DSpace …
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer DSpace …
[PDF][PDF] Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi, M Gümüş… - 2018 - core.ac.uk
BACKGROUND Standard first-line therapy for metastatic, squamous non–small-cell lung
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
[引用][C] Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
L Paz-Ares, A Luft, D Vicente, A Tafreshi, M Gumus… - 2018 - repository.ubn.ru.nl
BACKGROUND: Standard first-line therapy for metastatic, squamous non-small-cell lung
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
[引用][C] Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi… - New England Journal …, 2018 - cir.nii.ac.jp
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[引用][C] Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente… - … England Journal of …, 2018 - ub01.uni-tuebingen.de
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer DSpace …
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer DSpace …
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi… - NEW ENGLAND …, 2018 - iris.unito.it
Standard first-line therapy for metastatic, squamous non-small-cell lung cancer (NSCLC) is
platinum-based chemotherapy or pembrolizumab (for patients with programmed death …
platinum-based chemotherapy or pembrolizumab (for patients with programmed death …
[PDF][PDF] Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi, M Gümüş… - N Engl J Med, 2018 - academia.edu
BACKGROUND Standard first-line therapy for metastatic, squamous non–small-cell lung
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
[PDF][PDF] Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
L Paz-Ares, A Luft, D Vicente, A Tafreshi, M Gümüş… - N Engl J Med, 2018 - iris.unict.it
BACKGROUND Standard first-line therapy for metastatic, squamous non–small-cell lung
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …
cancer (NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with …